Subsidiary Adjusted EBITDA Growth (Excluding Lugano)
Subsidiary adjusted EBITDA was $345.8 million, up 8.8% year-over-year excluding Lugano, driven by consumer strength and operational leverage.
Branded Consumer Outperformance
Branded consumer net sales rose 3.7% and consumer subsidiary adjusted EBITDA increased 13.8%, with strong performances from businesses like Honey Pot and BOA Fit Systems.
BOA Fit Systems Competitive Momentum
BOA-equipped athletes earned more than 100 medals at the 2026 winter games (up from 10 podium winners four years earlier), signaling meaningful brand and product momentum.
Honey Pot Market Progress
The Honey Pot expanded distribution and product mix into the larger period care category, outpacing conventional and better-for-you competitors on Net Promoter Score and gaining runway for share growth.
Arnold Backlog and Capacity Expansion
Arnold ended the year with backlog more than 40% higher than prior year-end; initial production at a new Thailand facility is underway to add capacity and geopolitical redundancy.
Revenue Recovery and Organic Growth
Full-year net revenues were $1.9 billion (up 4.8% GAAP); excluding Lugano, net sales were $1.8 billion (up 3.9%), reflecting mid-single-digit organic revenue growth in 2025 (excluding Lugano).
Cash/Credit and Immediate Deleveraging Actions
Year-end liquidity included $68 million cash and ~$96 million available on the revolver; a January sale-leaseback of Altor facilities generated >$11 million used to pay down senior debt.
Clear Deleveraging Plan and Financial Targets
Management outlined a disciplined deleveraging plan (organic cash generation, targeted divestitures, potential repurchases) and provided 2026 subsidiary adjusted EBITDA guidance of $345M–$395M and a medium-term target leverage of 3.0x–3.5x.